NIH study finds those with shots had fewer N antibodies even after COVID infection
“The best vaccination is to get infected yourself. … It’s the most potent vaccination.” ~Dr. Anthony Fauci, 10/11/2004
It sure appears that the more we inject people with the mRNA gene therapy, the more the virus circulates and the more they get infected. All the data from the U.K., New Zealand, and our own Walgreens seems to indicate that the more you vax, the more you get infected. Just ask our very own vice president, who got infected just a few weeks after receiving her fourth jab, which is the supposed sweet spot of vaccine efficacy and antibody titer levels. Now, a new study by NIH researchers offers a possible glimpse into the mechanics of the leaky and illusory “immunity” of these novel shots.
In a preprint paper posted last week, the NIH researchers studied the N (nucleocapsid) antibody levels of those who participated in the Moderna clinical trial vs. the placebo group upon the unblinding of the participants. Their findings were earth-shattering.
“We analyzed data from 1,789 participants (1,298 placebo recipients and 491 vaccine recipients) with SARS-CoV-2 infection during the blinded phase (through March 2021). Among participants with PCR-confirmed Covid-19 illness, seroconversion to anti-N Abs at a median follow up of 53 days post diagnosis occurred in 21/52 (40%) of the mRNA-1273 vaccine recipients vs. 605/648 (93%) of the placebo recipients (p < 0.001).
Kudos to Igor Chudov for finding this paper that clearly our government agencies are not excited to advertise. Overall, the study’s authors found, “For any given viral copy number, the odds of anti-N seropositivity were 13.67 times higher for the placebo arm than the vaccine arm.” – READ MORE
Responses